Lupin Pharma, TPG Capital & EQT in talks to acquire Lalvani family-owned Vitabiotics

Indian drugmaker Lupin and private equity firms are exploring the acquisition of UK's Vitabiotics. The deal is valued at approximately one billion pounds. Several Indian companies had previously considered the acquisition but stepped back due to valuation concerns. Vitabiotics' Indian arm, Meyer Vitabiotics, contributes significantly to its annual sales. The nutraceutical market in India is experiencing rapid growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sNV1AuZ
via IFTTT